We are live on
!
Find out more
TCM
Tang Capital Management Portfolio holdings
AUM
$2.2B
1-Year Est. Return
156.35%
This Fund
S&P 500
This Quarter
Est. Return
+40.53%
1 Year Est. Return
+156.35%
3 Year Est. Return
+492.92%
5 Year Est. Return
+804.3%
10 Year Est. Return
+3,997.35%
AUM
$277M
AUM Growth
+$89.2M
(+48%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
14.73%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
3
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Heron Therapeutics
HRTX
|
+$34M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
+$6.36M |
| 3 |
BGMS
Bio Green Med Solution Inc
BGMS
|
+$983K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATYR
aTyr Pharma
ATYR
|
+$601K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.26% |
| 2 | Industrials | 0.74% |
Similar funds
LI
MIHAS
1SB
BOI
IHL
PCM
BCP
AAA
Tang Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Tang Capital Management held 6 positions worth $277M, up 48% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tang Capital Management deployed $40.8M of net new capital in Q1 2017, adding to 3 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 89% a quarter earlier, followed by Industrials.
On the sell side, the most notable exit was aTyr Pharma, an estimated $601K sold.
- Tang Capital Management added most to Heron Therapeutics in Q1 2017, an estimated $34M increase.
- Tang Capital Management fully exited aTyr Pharma in Q1 2017, selling an estimated $601K.
- Tang Capital Management's ten largest holdings make up 100% of its $277M portfolio in Q1 2017.
- Tang Capital Management opened 0 new positions and closed 1 in Q1 2017.
- Tang Capital Management's portfolio value rose 48% quarter-over-quarter to $277M.
Based on Tang Capital Management's 13F filing for Q1 2017, filed 15 May 2017.